Argenica receives ethics approval to start Phase 1 clinical trial for stroke
Argenica Therapeutics has received ethics approval to commence a Phase 1 clinical trial of healthy participants for a potential...
Continue reading
- Bone and Brain Axis
- Brain Plasticity
- Demyelinating Disease
- Epilepsy
- Functional Genomics
- Genetic Epidemiology
- Molecular Therapies
- Motor Neurone Disease
- Myositis
- Neurotrauma
- Palliative Care
- Parkinson’s
- Precision Nucleic Acid Therapeutics
- Restorative Neurology
- Spinal Cord Repair Laboratory
- Stroke
- 893 Researchers
- 800+ Collaborations
- 75+ PhDs Sponsored
Making a difference
A revolutionary surgical technology invented by Professor Minghao Zheng (The University of Western Australia and Perron Institute) is assisting in the delicate process of nerve repair to restore function to paralysed muscles.
Professor Zheng says the technique represents a paradigm shift and it is easy for surgeons to use to improve the lives of patients with complex nerve injuries. The research has received nation-wide media coverage.
Meet our research groups
Here at Perron Institute we’re bringing dedicated researchers and clinicians together to work on a brighter future for people living with neurological conditions.
Your donation will help us find answers for people with neurological disorders and give them hope.
Help with research
Clinical trials are an essential tool in modern medicine. We rely on voluntary participants to take part in our studies and trials for new treatments and interventions to improve patient’s quality of life. We are currently recruiting participants for the following studies and trials:
Our partners
With the support of our partners, Perron Institute is able to conduct major research into challenges in neurology.
Latest news
Keep informed with our latest updates.